Amneal Fights To Maintain Claims In Suboxone MDL
Amneal fought Friday to keep claims in multidistrict litigation accusing Indivior of embarking on a product-hopping scheme to stave off generic competition to the opiate addiction treatment Suboxone, telling a Pennsylvania...To view the full article, register now.
Already a subscriber? Click here to view full article